期刊文献+

在线血液透析滤过对维持性血液透析患者心脏结构和功能的影响 被引量:5

Effect of on-line hemodiafiltration on cardiac structure and function in maintenance hemodialysis patients
下载PDF
导出
摘要 目的探讨规律性在线高通量血液透析滤过对维持性血液透析(maintain hemodialysis,MHD)患者左心室结构和功能的维护作用和机理。方法按一定的纳入标准选择湖北医药学院附属人民医院血液净化中心MHD患者53例,随机分为单纯透析组(HD组)和透析+透析滤过组(HD+HDF组),于治疗前及6个月后用超声心动图分别测定各患者心脏结构和功能指标(LVDd、LVVd、E/A、EF和LVMI);在以上两时间点进行体检并抽取患者血标本分别检测患者基础状态指标(MAP、Hb、BMI、SCr)和透析相关慢性损害指标(CRP、IL-1a、a2-MG、PTH)。结果入选时两组患者在基础状态指标、透析相关慢性损害指标和心功能指标方面无显著差异;经不同治疗模式治疗6个月后,HD组在基础状态指标方面变化不明显,但在CRP、IL-1a、a2-MG、PTH等指标上有轻度升高;HD+HDF组患者在基础指标的血压和血红蛋白上和透析相关慢性损害指标上较前均有好转;治疗6个月后,HD组和HD+HDF组在E/A、EF、LVMI等心功能指标上均有所减退,但HD+HDF组较HD组的减退幅度明显较小。结论在维持性血液透析患者中采用HD+HDF模式更有助于减轻患者心脏结构和功能损害。 Objective To assess the effect and mechanism of regular on-line high-flux hemodiafiltration on left ventricular structure and function in maintenance hemodialysis patients. Methods Fifty-three maintenance hemodialysis patients were recruit in this Blood Purification Center, and were randomly assigned to regular hemodialysis (HD) group or regular hemodialysis plus on-line hemodiafiltration (HD+HDF) group. Before and after 6 months of the treatment, the left ventricular structure and function parameters (LVD d, LVVd, E/A, EF and LVMI), the basic condition parameters (MAP, Hb, BMI and SCr), and the HD-associated chronic injury parameters (CRP, IL-1a, a2-MG, and PTH) were determined. Results At the time of recruitment, there were no differences between the two groups in all these parameters. For the patients in HD group after 6 months treatment, there were no significant changes in basic condition parameters, but HD-associated chronic injury parameters became worse. For the patients in HD+HDF group after 6 months treatment, the basic condition parameters of BP and Hb, and all HD-associated chronic injury parameters improved. For patients in both HD and HD+HDF groups, all left ventricular structure and function parameters aggravated, but the degree of aggravation was less in HD+HDF group. Conclusion Regular on-line high-flux hemodiafiltration may alleviate the damage to left ventricular structure and function in maintenance hemodialysis patients.
出处 《中国血液净化》 2010年第10期538-541,共4页 Chinese Journal of Blood Purification
关键词 透析滤过 心脏结构 心脏功能 Hemodiafiltration Cardiac structure Cardiac function
  • 相关文献

参考文献7

  • 1Dhar S,Pressman GS,Subramanian S,et al.Natriuretic peptides and heart failure in the patient with chronic kidney disease:a review of current evidence[J].Postgrad Med J,2009,85:299-302.
  • 2McIntyre CW.Effects of hemodialysis on cardiac function[J].Kidney Int,2009,76:371-375.
  • 3Wang AY,Lam CW,Wang M,et al.Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients[J].Nephrol Dial Transplant,2009,24:1962-1969.
  • 4Zumrutdal A,Sezer S,Demircan S,et al.Cardiac troponin Ⅰ and beta 2 microglobulin as risk factors for early-onset alherosclerosis in patients on haemodialysis[J].Nephrology(Carlton),2005,10:453-458.
  • 5Coen G,Mantella D,Sardella D,et al.Asymmetric dimethylarginine,vascular calcifications and parathyroid hormone serum levels in bemodialysis patients[J].J Nephrol,2009,22:616-622.
  • 6张磊,崔美玉,许冬梅,李文斌,王尊松,魏勇,朱竹先.甲状旁腺激素与血液透析患者促红细胞生成素疗效的关系[J].中国血液净化,2009,8(4):203-205. 被引量:16
  • 7张本祥,尹忠诚.维持性血液透析患者hs-CRP和IL-6与心脏结构功能变化的临床观察[J].中国血液净化,2008,7(2):69-70. 被引量:5

二级参考文献16

  • 1朱维平,高飞,王益忠,李中华.继发性甲状旁腺功能亢进与贫血[J].中国血液净化,2005,4(4):232-232. 被引量:10
  • 2Danielson B. R-HuEPO hyporesponsiveness - who and why[J]? Nephrol Dial Transplant, 1995, 10 Suppl 2:69-73.
  • 3Dru eke TB. R-HuEPO hyporesponsiveness ? who and why[J]? Nephrol Dial Transplant, 1995,10 Suppl 2:62-68.
  • 4Rao DS, Shih M-S, Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia[J]. N Engl J Med, 1993,21,328:171-175.
  • 5Ure?a P, Eckardt KU, Sarfati E, et al. Serum erythropoietin and erythropiesis in primary and secondary hyperparathyroidism: effect of parathyroidectomy [J]. Nephron, 1991, 89 : 384-393.
  • 6McGonigle RJ, Wallin JD, Husserl F, et al. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure[J].J Lab Clin Med, 1984, Dec104:1016-1026.
  • 7Brancaccio D, Cozzolino M, Gallieni M. Hyperparathyroidism and Anemia in Uremic Subjects: A Combined Therapeutic Approach[J]. J Am Soc Nephrol, 2004,15 Suppl 1:S21-24.
  • 8Hsu SP, Peng YS, Pai MF, et al. Influence of relative hypoparathyroidism on the responsiveness to recombinant human erythropoietin in hemodialysis patients[J].Blood Purif, 2003,21:220-224.
  • 9Gallieni M, Corsi C, Brancaccio D. Byperparatbyroidism and anemia in renal failure [J]. Am J Nephron, 2000,20: 89-96.
  • 10Coen G, Calabria S, Bellinghieri G, et al. Parathyroidectomy in chronic renal failure: short-and long-term results on parathyroid function, blood pressure and anemia [J]. Nephron, 2001,88:149-155.

共引文献19

同被引文献39

  • 1李孜,杨立川,陈林,陈肖蕾,沙朝辉,付平.提高透析液钙浓度对透析中低血压患者血流动力学的影响[J].中国血液净化,2012,11(3):140-143. 被引量:5
  • 2王义涛,江菲菲.常规血液透析、高通量血液透析和血液透析滤过对血清甲状旁腺激(PTH)的清除效果比较[J].医学检验与临床,2010(4):74-76. 被引量:10
  • 3莫美华.血液透析滤过治疗尿毒症皮肤瘙痒的护理[J].透析与人工器官,2006,17(2):23-24. 被引量:4
  • 4The Inter national Quotidian Dialysis Registry: annunal report 2005. Hemodial Int, 2005,9 ( 3 ) : 203 - 209.
  • 5Locatelli F, Covic A, Chazot C, et al. Hypertension and cardio- vascular risk assessment in dialysis patients, Nephrol dial trans- plant,2004,19 ( 5 ) : 105821068.
  • 6Cheung AK, Sarnak M J, Yan G, et al. Cardiac diseases in Mainte- nancehemodialysis patients: results of the HEMO Study. Kidney Int ,2004 ,65 :2380 - 2389.
  • 7Rashid G, Benchetrit S, Fishman D, et al. The effects of ad- vanced glycation end products (AGEs) on endothelial cell nitric oxide synthase and rumor necrosis factor - a expression are AGEre- ceptor dependent. Kidney Int,2004,66 (3) :104 - 106.
  • 8Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med,2002, 347:2010 - 2019.
  • 9Rabindranath KS, Strippoli GFM, Roderick P, et al. Comparison of hemodialysis, hemofiltration, and Acetate - Free Biofiltration Ltration for ESRD:Systematic Review. Am J Kidney Dis,2005,45 : 437 - 447.
  • 10Lommi J, Pulkkit K. Haemodynamic. neuroendocrine and metabol- ic cor2 relates of circulating cytokine concentration in congestive heart failure. Eur Heart J, 1997,18 : 1620 - 1625.

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部